Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
79.63 USD | +3.35% | +5.33% | +3.20% |
May. 06 | Argus Adjusts Price Target on Bio-Techne to $95 From $90, Keeps Buy Rating | MT |
May. 02 | UBS Adjusts Price Target on Bio-Techne to $90 From $80, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.20% | 12.55B | |
+23.37% | 47.02B | |
+49.96% | 41.86B | |
-0.94% | 41.76B | |
-4.32% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
-2.67% | 11.82B | |
+30.23% | 12.34B | |
+20.99% | 11.8B |
- Stock Market
- Equities
- TECH Stock
- News Bio-Techne Corporation
- Transcript : Bio-Techne Corporation Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 08